May 9, 2024
The American College of Radiology® (ACR®) responded to a targeted request for information from U.S. Rep. Ami Bera, MD, (CA-6), a member of the bipartisan House Task Force on Artificial Intelligence (AI), regarding the state of health care artificial intelligence (AI). Rep. Bera’s RFI included an extensive list of questions focused on various aspects of healthcare AI oversight, implementation, use and innovation.

ACR highlighted examples of real-world applications of healthcare AI and recommended ways to enhance product transparency and oversight mechanisms moving forward, including leveraging public-private partnerships. The College provided concepts that would be important in any future value-based payment approach looking at ensuring quality implementation, governance and use of high-value AI tools. ACR noted that not all currently reimbursed uses of AI are adding value to patients or the health system.

ACR also highlighted novel oversight questions posed by foundation models/generative AI used to enable higher risk functions such as diagnosis or treatment. The College noted the U.S. Food and Drug Administration may benefit from expanded authorities to meet future regulatory challenges and opportunities.

For more information about ACR’s AI-related programs and initiatives, visit the ACR Data Science Institute website. For questions about the ACR comment submission or AI oversight policy, contact Michael Peters, ACR Senior Government Affairs Director.

Related ACR News

  • States Still in Session Debate Healthcare Bills

    ACR continues to monitor radiology-specific legislation. With some states still in session, active awareness at the chapter level remains critical.

    Read more
  • Priscilla J. Slanetz, MD, MPH Named RAN Advocate of the Year

    ACR spoke with Dr. Slanetz about her involvement in advocacy and what the Advocate of the Year award means to her.

    Read more
    Dr. Slanetz receiving the RAN Advocate of the Year
  • ACR Leaders Discuss AI with HHS; POTUS AI Plan Released

    Funding for NIH in federal fiscal year (FY) 2026 is uncertain until Congress returns from its August recess.

    Read more